Have a personal or library account? Click to login

Malignant Acanthosis Nigricans, Florid Cutaneous Papillomatosis and Tripe Palms Syndrome Associated with Gastric Adenocarcinoma - a Case Report

Open Access
|Dec 2015

References

  1. 1. Rogers DL. Acanthosis nigricans. Semin Dermatol 1991;10:160-3.
  2. 2. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol 1994;31(1):1-19.10.1016/S0190-9622(94)70128-8
  3. 3. Kalus AA, Chien AJ, Olerud JE. Diabetes mellitus and other endocrine diseases. In: Wolf K, Goldsmith LA, Katz SI, Gilchrist BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in generale medicine. 7th edition. New York: Mc Graw Hill Med; 2008. p. 1461-70.
  4. 4. Olek-Hrab K, Silny W, Zaba R, Osmola-Mankowska A, Machiewicz-Wysocka M, Danczak-Pazdrowska A. Co-occurrrence of acanthosis nigricans and bladder adenocarcinoma - case report. Contemp Oncol (Pozn) 2013;17(3):327-30.
  5. 5. Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J 2014;5(3):239-49.10.4103/2229-5178.137765414420625165638
  6. 6. Barbato MT, Criado PR, Silva AK, Averbeck E, Guerine MB, Sa NB. Association of acanthosis nigricans and skin tags with insulin resistence. An Bras Dermatol 2012;87(1):97-104.10.1590/S0365-0596201200010001222481657
  7. 7. Munoz-Perez MA, Camacho F. Acanthosis nigricans: a new cutaneous sign in sever atopic dermatitis and Down syndrome. J Eur Acad Dermatol Venereol 2001;15:325-7.10.1046/j.1468-3083.2001.00239.x
  8. 8. Ceylan C, Alper S, Kilinc I. Leser-Trelat sign. Int J Dermatol 2002;41:687-8.10.1046/j.1365-4362.2002.01600.x12390193
  9. 9. Pollitzer S. Acanthosis nigricans. In: Unna PG, Morris M, Besnier E, et al, editors. International atlas of rare skin disease. London: HK Lewis and Co; 1891. Chapter 10; p. 1-3.
  10. 10. Janovsky V. Acanthosis nicricans. In: Unna PG, Morris M, Besnier E, et al, editors. International atlas of rare skin diseases. London; HK Lewis and Co; 1891. Chapter 11; p. 4-5.
  11. 11. Brown J, Winkelmann RK. Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) 1968;47:33-51.10.1097/00005792-196801000-00002
  12. 12. Curth HO. The necessity of distinguishing four types of acanthosis nigricans. In: Jadassohn W, Schirren CG, editors. Proceedings of XIII International Congress of Dermatology; 1967 Jul 31-Aug 5; Munchen, Germany. Berlin: Springer–Verlag; 1968. p. 557-8.
  13. 13. Van Hagen P, Wijnhoven BPL, Torcque LA, Tilanus HW, van Lanschort JJB, Prens EP. Paraneoplastic acanthosis nigricans, Leser-Trelat and tripe palms associated with gastroesophageal junction adenocarcinoma: a case report. J Med Cas 2011;2(5):197-200.
  14. 14. Pavithran K, Karunakaran M, Palit A. Disorders of keratinisation. In: Valia RG, Ameet RV, editors. IADVL textbook of dermatology. 3rd ed. Munmbai: Bhalani Publ House; 2008. p. 1009-11.
  15. 15. Kondo Y, Umegaki N, Terao M, Murota H, Kimura T, Karayama I. A case of generalized acanthosis nigricans with positive lupus erythematosus-related autoantibodies and antimicrosomal antibody: autoimmune acanthosis nigricans? Case Rep Dermatol 2012;4(1):85-91.
  16. 16. Sawatkar GU, Dogra S, Bhadada SK, Kanwar AJ. Acanthosis nigricans – an uncommon cutaneous adverse effects of a common medication: report of two cases. Indian J Dermatol Venereol Leprol 2013;79:553.10.4103/0378-6323.11311223760338
  17. 17. Erickson L, Lipschutz DE, Wrigley W, Kearse WO. A peculiar cutaneous reaction to repeated injections of insulin. JAMA 1969;209:934-5.10.1001/jama.1969.03160190056019
  18. 18. Brinca A, Cardoso JC, Brites MM, Tellechea O, Figueiredo A. Florid cutaneous papillomatosis and acanthosis nigricans maligna revealing gastric adenocarcinoma. An Bras Dermatol 2011;86(3):573-7.10.1590/S0365-05962011000300025
  19. 19. Andreev VC. Malignant acanthosis nigricans. Semin Dermatol 1984;3:265-72.
  20. 20. Ortega-Loayza AG, Ramos W, Gutierrez EL, Paz PC, Bobbio L, Galarza C. Cutaneous manifestations of internal malignancies in tertiary health care hospital of a developing country. An Bras Dermatol 2010;85:736-42.10.1590/S0365-0596201000050002621152807
  21. 21. DeWitt CA, Buescher LS, Stone SP. Cutaneous manifestations of internal malignant diseases: cutaneous paraneoplastic syndromes. In: Wolf K, Goldsmith LA, Katz SI, Gilchrist BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 7th edition. New York: Mc Graw Hill Med; 2008. p. 1493-507.
  22. 22. Jakubovic BD, Sawires HF, Adam DN. Occult cause of paraneoplastic acanthosis nigricans in a patient with known breast DCIS: case and review. Curr Oncol 2012;19(4):e299-302.10.3747/co.19.997
  23. 23. Abu-Safieh Y, Khelfa S. Acanthosis nigricans: aA presentation of gastric adenocarcinoma. Arab J Gasroenterol 2011:12:156-7.10.1016/j.ajg.2011.04.001
  24. 24. Braverman IM. Skin manifestations of internal malinancy. Clin Geriatr Med 2002;18(1):1-19.10.1016/S0749-0690(03)00031-4
  25. 25. Scully C, Hegarty A. The oral cavity and lips. In: Burns T, Breathnac H, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. Oxford: Wiley-Blackwell; 2010; Chapter 69.10.1002/9781444317633.ch69
  26. 26. Soto Ortiz JA, Amezcua Rosas G, Guardado Luevanos I, Bologna Molina R. Acanthosis nigricans. Manifestaciones bucales. Dermatol Rev Mex 2011;55(1):47-50.
  27. 27. Swineford SL, Drucker CR. Palliative treatment of paraneoplastic acanthosis nigricans and oral florid papillomatosis with retinoids. J Drugs Dermatol 2010;9(9):1151-3.
  28. 28. Schulmann K, Strate K, Pox CP, Wieland U, Kreuter A. Paraneoplastic acanthosis nigricans with cutaneous and mucosal papillomatosis preceding recurrence of a gastric adenocarcinoma. J Clin Oncol 2012;30(32):e325-6.10.1200/JCO.2012.42.545423008315
  29. 29. Amjad M, Arfan-ul-Bari, Shah AA. Malignant acanthosis nigricans: an early diagnostic clue. J Coll Physicians Surg Pak 2010;20(2):127-9.
  30. 30. Pentenero M, Carrozzo M, Pagano M, Gandolfo S. Oral acanthosis nigricans, tripe palms and sign of Leser-Trelat in a patient with gastric adenocarcinoma. Int J Dermatol 2004;43:530-2.10.1111/j.1365-4632.2004.02159.x15230897
  31. 31. Mukai T. Acanthosis nigricans. Acta Derm (Kyoto) 1929;14:447-60.
  32. 32. Lenzner U, Ramsauer J, Petzoldt W, Meigel W. Acanthosis nigricans maligna. Case report and review of the literature. Hautarzt 1998;49:41-7.10.1007/s0010500506999522192
  33. 33. Nair PS, Moorthy P, Suprakasan S, Jayapalan S, Sarin M. Malignant acanthosis nigricans with liver secondaries from an occult primary adenocarcinoma of gastrointestinal tract. Indian J Dermatol Venereol Leprol 2005;71(3):197-8.10.4103/0378-6323.1623916394413
  34. 34. Kleikamp S, Bohm M, Frosch P, Brinkmeier T. Acanthosis nigricans, papillomatosis mucosae aund „tripe palms“ in a patient with metastasized carcinoma. Dtsch Med Wochenschr 2006;131(21):1209-13.10.1055/s-2006-94175316721709
  35. 35. Oh CW, Yoon J, Kim CY. Malignant acanthosis nigricans associated with ovarian cancer. Case Rep Dermatol 2010;2(2):103-9.10.1159/000317116291437020689633
  36. 36. Kaminska-Winciorek G, Brzezinska-Wcislo L, Lis-Swiety A, Krauze E. Paraneoplastic type of acanthosis nigricans in patient with hepatocellular carcinoma. Adv Med Sci 2007;52:254-6.
  37. 37. Lazzarini R, Simone K, Queiroz G, Courral I, Magliari ME, Feder CK, et al. Acantose nigricante maligna: realato de caso. Dermatol Online J 2014;20(4):22377.10.5070/D3204022377
  38. 38. Costa MC, Martinez NS, Belicha MG, Leal F. Acanthosis nigricans and ”tripe palm” as paraneoplastic manifestations of metastatic tumor. An Bras Dermatol 2012;87(3):498-500.10.1590/S0365-05962012000300030
  39. 39. Yang YH, Zhang RZ, Kang DH, Zhu WY. Three paraneoplastic signs in the same patient with gastric adenocarcinoma. Dermatol Online J 2013;19(7):18966.10.5070/D3197018966
  40. 40. Stawczyk-Macieja M, Szczerkowska-Dobosz A, Nowicki R, Majewska H, Dubovik M, Sokolowska-Wojdylo M. Malignant acanthosis nigricans, florid cutaneous papillomatosis and tripe palms syndrome associated with gastric adenocarcinoma. Postepy Dermatol Alergol 2014;31(1):56-8.10.5114/pdia.2014.40663395205924683401
  41. 41. Kebria MM, Belinson J, Kim R, Mekhail TM. Malignant acanthosis nigricans, tripe palms and sign of Leser-Trelat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literature. Gynecol Oncol 2006;101(2):353-5.10.1016/j.ygyno.2005.12.02416443260
  42. 42. Schwartz RP, Burgess GH. Florid cutaneous papillomatosis. Arch Dermatol 1978;114:1803-6.10.1001/archderm.1978.01640240045015
  43. 43. White H. Acanthosis nigricans and wart like lesions associated with metastatic carcinoma of the stomach. Cutis 1976;17:931-3.
  44. 44. Gross G, Pfister H, Hellenthal B, Hagedom M. Acanthosis nigricans maligna. Clinical and virological investigations. Dermatologica 1984;168:265-72.10.1159/000249721
  45. 45. Breathnach SM, Wells GC. Acanthosis palmaris: tripe palms. A distinctive pattern of palmar keratoderma frequently associated with internal malignancy. Clin Exp Dermatol 1980;5:181-9.10.1111/j.1365-2230.1980.tb01686.x6449322
  46. 46. Cohen PR, Grossman ME, Almeida L, Kurzrock R. Tripe palms and malignancy. J Clin Oncol 1989;7:669-78.10.1200/JCO.1989.7.5.6692651581
  47. 47. Koulaouzidis A, Leiper K. Tripe palms or acanthosis palmaris. Intern Med J 2007;37:502.10.1111/j.1445-5994.2007.01374.x17547729
  48. 48. Saeed H, Massarweh S. Images in clinical medicine. Hypertrophic pulmonary osteoarthropathy and tripe palms. N Engl J Med 2012;366(4):360.10.1056/NEJMicm111086222276825
  49. 49. Cox NH, Coulsin IH. Systemic diseases and skin. In: Burns DA, Breathnach SM, Cox NH, Grifits CEM, editors. Rook’s textbook of dermatology. Oxford: Blackwell Publishing Ltd; 2010.
  50. 50. Abreu Velez AM, Howard MS. Diagnosis and treatment of cutaneous paraneoplastic disorders. Dermatol Ther 2010;23:662-75.10.1111/j.1529-8019.2010.01371.x21054710
  51. 51. Clarke J. Malignant acanthosis nigricans. Clin Exp Dermatol 1977;2:167-70.10.1111/j.1365-2230.1977.tb01561.x884896
  52. 52. Moore RL, Devere TS. Epidermal manifestations of internal malignancy. Dermatol Clin 2008;26(1):17-29.10.1016/j.det.2007.08.00818023768
  53. 53. Fabroni C, Gimma A, Cardinali C, Scocco GL. Tripe palms associated with malignant acanthosis nigricans in a patient with gastric adenocarcinoma: a case report and review of the literature. Dermatol Online J 2012;18(11):15.10.5070/D37BH1H290
  54. 54. Heaphy MR, Millns JL, Schroeter AL. The sign of Leser-Trelat in a case of adenocarcinoma of the lung. J Am Acad Dermatol 2000;43(2 Pt 2):386-90.10.1067/mjd.2000.10496710901731
  55. 55. Haase I, Hunzelmann N. Activation of epidermal growth factor receptor/ERK signaling correlates with suppressed differentiation in malignant acanthosis nigricans. J Invest Dermatol 2002:118(5):891-3.10.1046/j.1523-1747.2002.17631.x11982771
  56. 56. Ghosh U, Thomas M, Mathai S. Syndrome of insulin resistance with acanthosis nigricans, acral hypertrophy and muscle cramps in an adolescent – a rare diagnosis revised. Indian J Pediatr 2014;81(12):1389-91.10.1007/s12098-014-1503-724912440
  57. 57. Judge MR, M.Lean WHJ, Munro CS. Disorders of keratinisation. In: Burns DA, Breathnach SM, Cox NA, Griffits CEM, editors. Rook’s Textbook of Dermatology. Oxford: Blackwell Publishing Ltd; 2010. Chapter 19.10.1002/9781444317633.ch19
  58. 58. Koyama S, Ikeda K, Sato M, Shibahara K, Yuhara K, Fukutomi H, et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol 1997;32(1):71-7.10.1007/BF012132999058298
  59. 59. Hida Y, Kubo Y, Nishio Y, Murakami S, Fukumoto D, Sayama K, et al. Malignant acanthosis nigricans with enhanced expression of fibroblast growth factor receptor 3. Acta Derm Venereol 2009;89:435-7.10.2340/00015555-0666
  60. 60. Akovbyan VA, Talanin NI, Arifov SS, Tukhvatullina ZG, Musabayev AN, Baybekov IM, et al. Successful treatment of acanthosis nigricans with etretinate. J Am Acad Dermatol 1994;31:118-20.10.1016/S0190-9622(09)80242-9
  61. 61. Bohm M, Luger TA, Metze D. Treatment of mixed-type acanthosis nigricans with topical calcipotriol. Br J Dermatol 1998;139:932-4.10.1046/j.1365-2133.1998.02538.x9893209
  62. 62. Zayed A, Sobhi RM, Abdel Halim DM. Using trichloroacetic acid in the treatment of acanthosis nigricans: a pilot study. J Dermatol Treat 2014;25(3):223-5.10.3109/09546634.2012.67419422494198
Language: English
Page range: 5 - 14
Published on: Dec 10, 2015
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2015 Mirjana Paravina, Dragana Ljubisavljević, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.